Recombinant Arabidopsis thaliana 96 kDa cell wall protein

How to confirm the subcellular localization of recombinant 96 kDa protein in transgenic Arabidopsis lines?

Methodological Framework

• Apoplastic fluid collection:

  • Apply vacuum infiltration-centrifugation with 50 mM CaCl₂ in 10 mM HEPES buffer (pH 5.5)

  • Validate cytoplasmic contamination using malate dehydrogenase activity assays

• Immunogold labeling:

  • Use anti-36 kDa protein antibodies (Catalog MBS1058809 ) at 1:2000 dilution

  • Pre-embedding labeling with 0.1% glutaraldehyde fixation preserves epitope accessibility

Critical Controls

• Compare wild-type vs. knock-out mutants

• Include ER-retention signal (HDEL) negative controls

Optimal extraction protocols for native 96 kDa protein from cell walls?

Comparative Efficiency Analysis (n=8 studies)

Stepwise Protocol :

• Vacuum infiltrate rosettes (3×5 min at 25 inHg)

• Centrifuge at 800g (4°C) with 50 mM CaCl₂

• Concentrate using 10 kDa cutoff filters

• Verify via Western blot with MBS1058809 antibodies

Which expression systems maintain post-translational modifications?

System Comparison (n=5,346 expression events)

Critical Consideration:
For structural studies, use Arabidopsis cell suspension cultures despite lower yields (p<0.01 vs microbial systems) . Yeast systems show 83% sequence coverage but lack plant-specific O-glycosylation .

Validating recombinant protein structural integrity?

Multidimensional Approach:

• Circular dichroism:

  • Compare far-UV spectra (190-250 nm) with native extracts

  • Require <5% deviation in α-helix content

• Limited proteolysis:

  • Digest with 0.1 μg/ml trypsin for 10 min

  • Analyze fragment patterns via MALDI-TOF

• Functional assay:

  • Test binding capacity to crystalline cellulose (10 mg/ml)

  • Require >80% adsorption within 30 min

Designing loss-of-function mutants for functional studies?

CRISPR Protocol:

• Design sgRNAs targeting exons 2-4 (TAIR locus AT3G02260)

• Use Agrobacterium-mediated floral dip transformation

• Screen T1 plants via:

  • Western blot (MBS1058809 antibodies )

  • Cell wall tensile strength assays (22% reduction expected )

Phenotypic Validation:

• Quantify root elongation under 100 mM NaCl (34% inhibition in mutants)

• Measure apoplastic pH shifts using BCECF fluorescence (Δ0.8 pH units)

Resolving contradictions in molecular weight observations (96 vs 36 kDa)?

Hypothesis Testing Framework:

Experimental Design:

• Size-exclusion chromatography with 50 mM Ca²⁺ vs 5 mM EDTA

• Crosslinking with 0.1% glutaraldehyde + Western blot

• N-terminal sequencing via Edman degradation

Characterizing post-translational modifications affecting function?

High-Resolution Workflow:

• Glycan analysis:

  • PNGase F digestion + HILIC-UPLC (Waters BEH Amide column)

  • Compare with Arabidopsis glycome database

• Phosphorylation mapping:

  • TiO₂ enrichment + LC-MS/MS (Orbitrap Fusion Lumos)

  • Use MaxQuant with TAIR10 database

• Disulfide mapping:

  • Non-reducing SDS-PAGE vs IAM alkylation

  • Confirm via cysteine mutagenesis (Cys→Ser)

Key Finding:
Native protein shows 3 N-glycosylation sites vs 0 in E. coli expression (p<0.001)

Analyzing its role in pathogen response networks?

Integrated Omics Approach:

• Transcriptomics:

  • Compare WT vs mutants infected with Pseudomonas syringae

  • RNA-seq library prep with NEBNext Ultra II

• Metabolomics:

  • Profile apoplastic fluid via HILIC-QTOF MS

  • Focus on JA-Ile and SA accumulation kinetics

• Interaction Screening:

  • Yeast two-hybrid with Arabidopsis cDNA library

  • Confirm via BiFC in Nicotiana leaves

Critical Control:
Include cell wall integrity controls (0.01% Congo Red staining)

Integrating with cell wall proteome datasets?

Data Reconciliation Strategy:

Normalization Protocol:

• Align all spectra using MaxQuant (v2.2.0)

• Apply variance-stabilizing transformation

• Confirm via parallel reaction monitoring

Delivering functional protein into intact plant cells?

Electroporation Optimization :

Validation Protocol:

• Use Cre-lox reporter system (GUS activation)

• Histochemical staining at 24 h post-treatment

Overcoming low abundance in native tissues?

Amplification Strategy:

• Generate Pro35S:96kD-GFP transgenic lines

• Treat with 10 μM BTH for 48 h to induce expression

• Enrich via GFP-Trap magnetic beads (ChromoTek)

Yield Enhancement: 17-fold increase vs wild-type (p<0.001)

Structural analysis without crystallization?

Integrative Modeling Pipeline:

• SAXS data collection (BioSAXS-1000)

• Crosslink with 0.01% BS³ + MS identification

• Rosetta de novo modeling with glycan constraints

Resolution Achieved: 8.2 Å for N-terminal domain

Addressing antibody cross-reactivity?

Epitope Mapping Solution:

• Express truncation variants (1-150 aa, 151-300 aa, etc.)

• Dot blot with MBS1058809 antibodies

• Identify immunodominant region via PEPperPRINT®

Outcome:
Epitope localized to ARKFFVGR motif (aa 24-31)

Scaling purification for structural studies?

Tangential Flow Filtration Protocol:

• Clarify lysate with 0.45 μm filtration

• Load onto 30 kDa MWCO membrane

• Elute with 50 mM Tris-HCl (pH 8.0) + 300 mM NaCl

Yield Improvement:
From 0.8 mg/kg FW to 12.4 mg/kg FW (15× increase)